UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trichinella britovi outbreak in north-west Italy, 2019-2020: beware of wild boar

International journal of infectious diseases, 2022-03, Vol.116, p.S77-S78

2022

Volltextzugriff (PDF)

Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children

The Journal of infectious diseases, 1995-05, Vol.171 (5), p.1317-1322

1995

Volltextzugriff (PDF)

Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

Journal of hepatology, 2018-04, Vol.68, p.S525-S526

2018

Volltextzugriff (PDF)

FRI-361 - Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

Journal of hepatology, 2018-04, Vol.68, p.S525-S526

2018

Volltextzugriff (PDF)

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients

Antiviral research, 2014-08, Vol.108, p.44-47

2014

Volltextzugriff (PDF)

The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria

Infection, 2011-12, Vol.39 (6), p.555-561

2011

Volltextzugriff (PDF)

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

Journal of antimicrobial chemotherapy, 2011, Vol.66 (1), p.224-225

2011

Volltextzugriff (PDF)

Is peritoneal fluid a sanctuary site for HIV?

Journal of antimicrobial chemotherapy, 2010-09, Vol.65 (9), p.2052-2053

2010

Volltextzugriff (PDF)

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

The Lancet (British edition), 2014-06, Vol.383 (9936), p.2222-2231

2014

Volltextzugriff (PDF)

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus

Journal of antimicrobial chemotherapy, 2007-03, Vol.59 (3), p.565-568

2007

Volltextzugriff (PDF)

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

The Lancet (British edition), 2014-07, Vol.384 (9939), p.241-248

2014

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

The Lancet (British edition), 2013-03, Vol.381 (9868), p.735-743

2013

Volltextzugriff (PDF)

Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

The Journal of infectious diseases, 2015-01, Vol.211 (2), p.178-186

2015

Volltextzugriff (PDF)

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C

Liver international, 2021-08, Vol.41 (8), p.1802-1814

2021

Volltextzugriff (PDF)

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.281-289

2012

Volltextzugriff (PDF)

Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins: Focus on HIV/AIDS

The Journal of infection, 2008, Vol.57 (1), p.78-81

2008

Volltextzugriff (PDF)

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

Journal of antimicrobial chemotherapy, 2019-11, Vol.74 (11), p.3295-3304

2019

Volltextzugriff (PDF)

Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study

The Internet journal of infectious diseases, 2013-05, Vol.207 (9), p.1359-1369

2013

Volltextzugriff (PDF)

Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view

Journal of antimicrobial chemotherapy, 2024-10, Vol.79 (10), p.2662-2667

2024

Volltextzugriff (PDF)

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354

2008

Volltextzugriff (PDF)

Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

Journal of antimicrobial chemotherapy, 2024-06, Vol.79 (6), p.1279

2024

Volltextzugriff (PDF)

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

The Lancet (British edition), 2008-04, Vol.371 (9622), p.1417-1426

2008

Volltextzugriff (PDF)

CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

The lancet HIV, 2015-03, Vol.2 (3), p.e98-e106

2015

Volltextzugriff (PDF)

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

Journal of antimicrobial chemotherapy, 2018-12, Vol.73 (12), p.3460-3470

2018

Volltextzugriff (PDF)

1 – 25 von 964

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(793)
Mit Volltextzugriff
(670)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Trichinella britovi outbreak in north-west Italy, 2019-2020: beware of wild boar

Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children

Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

FRI-361 - Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients

The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria

Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

Is peritoneal fluid a sanctuary site for HIV?

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins: Focus on HIV/AIDS

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study

Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

Suchergebnisse filtern